secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0001493152-24-005736
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions Q2 revenue up 114% YoY to $0.76M; net loss widens
---------------------------------------------------------------------------

- Revenue from sales of goods increased 114% to $0.76M in Q2 FY2024, and 337% to $1.56M for six months ended Dec 31, 2023.
- Net loss attributable to INBS for six months was $4.39M, compared to $1.63M in prior year, driven by acquisition of IFP.
- Company raised ~$4.38M in October 2023 public offering; net proceeds ~$3.79M; ended quarter with $1.12M cash.
- Expanded into New Zealand market; customer portfolio includes VKVP Haulage, Titan Cranes, P&O Ferries; NATA accreditation for confirmatory drug testing.
- Product sales grew 30% for cartridges and 91% for readers in six months; management expects continued rapid growth in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224005736/0001493152-24-005736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224005736/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer